CLINICAL_TRIALS
trial_result
· 2020-07-27
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis [Phase 2]
Summary
Phase 2 study of avacopan (CCX168) in ANCA-associated vasculitis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Vasculitis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-27